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Abstract
Background: Malaria is an endemic disease in Yemen and is responsible for 4.9 deaths per 100,000 population per
year and 43,000 disability adjusted life years lost. Although malaria in Yemen is caused mainly by Plasmodium
falciparum and Plasmodium vivax, there are no sequence data available on the two species. This study was
conducted to investigate the distribution of the Plasmodium species based on the molecular detection and to
study the molecular phylogeny of these parasites.
Methods: Blood samples from 511 febrile patients were collected and a partial region of the 18 s ribosomal RNA
(18 s rRNA) gene was amplified using nested PCR. From the 86 positive blood samples, 13 Plasmodium falciparum
and 4 Plasmodium vivax were selected and underwent cloning and, subsequently, sequencing and the sequences
were subjected to phylogenetic analysis using the neighbor-joining and maximum parsimony methods.
Results: Malaria was detected by PCR in 86 samples (16.8%). The majority of the single infections were caused by
P. falciparum (80.3%), followed by P. vivax (5.8%). Mixed infection rates of P. falciparum + P. vivax and P. falciparum
+ P. malariae were 11.6% and 2.3%, respectively. All P. falciparum isolates were grouped with the strain 3D7, while
P. vivax isolates were grouped with the strain Salvador1. Phylogenetic trees based on 18 s rRNA placed the
P. falciparum isolates into three sub-clusters and P. vivax into one cluster. Sequence alignment analysis showed
5-14.8% SNP in the partial sequences of the 18 s rRNA of P. falciparum.
Conclusions: Although P. falciparum is predominant, P. vivax, P. malariae and mixed infections are more prevalent
than has been revealed by microscopy. This overlooked distribution should be considered by malaria control
strategy makers. The genetic polymorphisms warrant further investigation.
Background
Malaria still continues to be a devastating global public
health problem in more than 100 countries with 3.2 bil-
lion people being at risk [1]. Of this number, 300-500
million people contract the disease each year, resulting
in 2-3 million deaths [2]. This includes 1 million chil-
dren of less than five years of age [3].
The genus Plasmodium consists of nearly 200 species
that infect humans, birds, reptiles and mammals. It
belongs to the phylum Apicomplexa. Five Plasmodium
species have been known to infect humans: P. falci-
parum, P. vivax, P. malariae, P. ovale,a n dP. knowlesi
[4]. Much work on molecular phylogeny has focused on
the relationship between Plasmodium species and the
origin of human malaria [5-7]. Although the 18 s rRNA
gene appears to be robust for phylogenetic analysis, its
sequences should be analysed carefully since the gene
could be expressed as one of the three types during the
different developmental stages of the malaria parasite
[4,8]. Asexual type (A) and sporozoite type (S) were
found in P. falciparum, P. berghei, P. vivax,a n do t h e r
species [4,9] while oocyst type (O) has been reported in
P. vivax [10].
Yemen is a country in the East Mediterranean region
where the highest incidence of malaria has been regis-
tered after Afghanistan [11] and is responsible for 4.9
deaths per 100000 per year and 43000 disability adjusted
life years (DALYs) lost [12]. Giemsa microscopy is the
most common diagnostic tool used in this country. This
technique has drawbacks, however, in terms of detecting
low parasitemic cases and the proper identification of
mixed infection could actually underestimate the malaria
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applied for the first time, in this country, to investigate
the molecular epidemiology of malaria. The study will
indicate the magnitude of malaria co-infection which
should be considered in clinical case management. In
addition, malaria strains, genetic polymorphism and the
molecular phylogeny of Yemen Plasmodium isolates will
be studied.
Methods
Study area
The present study was conducted in five governorates with
a total population of 7.9 million [13]. The selected gover-
norates included Taiz and Hodeidah, which represent the
mountainous hinterland and coastal areas, respectively;
and Rymah, Dhamar and Sana’a from the highland areas.
Most houses, especially in the rural areas, have a wooden
roof. Occupations include agriculture, fishing, livestock
and handicrafts. The peak time of malaria transmission in
the coastal areas occurs in winter (October-April), while
in the western mountains, the peak occurs in the summer
(May-September). In the highland areas, which are located
at more than 2000 metres above sea level, the transmission
of malaria occurs throughout the year [14]. Anopheles ara-
biensis is the main vector in the country but Anopheles
culicifacies plays an important role in the transmission of
malaria in the coastal area. Anopheles sergenti has also
been reported in the mountainous hinterland and high-
land areas [14]. There is a paucity of comparative data on
mortality and morbidity caused by malaria in the three
malaria endemic areas. An observational study showed
that mortality rate among children with severe malaria
was 2.4% and 3.5% for costal and hinterlands, respectively
[15]. However, no data were available on mortality rate in
the highland areas.
Sample collection and genomic DNA preparation
A total of 511 finger-prick blood samples were collected
from symptomatic patients attending hospitals or medi-
cal centres for the treatment of malaria. Blood from fin-
ger pricks from febrile patients was collected and
spotted on Whatman 3 MM filter papers (Whatman
International Ltd., Maidstone, England) and slides to
prepare thin and thick blood films. Each blood spot on
Whatman filter paper was allowed to air-dry and was
stored in a separate sealed plastic bag at room tempera-
ture until DNA extraction was required. Parasite geno-
mic DNA was extracted from the blood collected on
filter paper using QIAgen DNA Mini Kit blood and tis-
sue (QIAGEN, cat. no. 51306, Germany) according to
the manufacturer’s instructions. Briefly, a disc was
punched out from the blood spot using a pre-flamed
paper puncher and placed in 1.5 ml centrifuge tubes
using clean, flamed forceps.
Polymerase chain reaction (PCR)
Genus-and species-specific nested PCR assays based on
the 18 s rRNA gene were used to detect and identify
Plasmodium species as previously reported [16]. Primary
PCR was carried out using genus-specific primers
(rPLU1 and rPLU5). PCR reaction was run in a total of
25 μL reaction mixture containing 4 μLg e n o m i cD N A ,
1× i-Taq™buffer including MgCl2 (iNtRON BIOTECH-
NOLOGY, Seoul, Korea), 250 μM dNTP (iNtRON BIO-
TECHNOLOGY, Seoul, Korea)), 200 nM of each primer
and 1.25 U of i-Taq™DNA polymerase (iNtRON BIO-
TECHNOLOGY, Seoul, Korea). Secondary PCR was
carried out using species-specific primers (rFAL1/
rFAL2, rVIV1/rVIV2, rMAL1/rMAL2 and rOVA1/
rOVA2); each primer pair was placed in a single tube.
PCR mixtures were as mentioned above, except that
2 μL of the first PCR product was used as a template in
the secondary PCR.
The cycling conditions for primary PCR were as fol-
lows: an initial denaturation step at 95°C for 10 minutes,
then 40 cycles at 94°C for 20 seconds, annealing at 55°C
for 20 seconds, extension at 72°C for 1 minute, and a
final extension at 72°C for 5 minutes. The reaction was
terminated by reducing the product temperature to 10°
C. PCR products were stored at -20°C until analysis.
Secondary PCR used similar cycling conditions except
that the number of cycles was reduced to 35 cycles.
Cloning and DNA sequencing
The PCR product comprising 17 positive samples (13 P.
falciparum and 4 P. vivax), representing different geo-
graphical areas, was selected for cloning and subsequent
sequencing. A partial sequence (~1200 bp) of the 18 s
rRNA gene was amplified with primers rPLU6 and
rPLU5. PCR was carried out in a volume of 20 μlm i x -
ture containing 1× Phusion HF buffer (Finnzymes, Fin-
land), 200 μM of each dNTP (Finnzymes) and 400 nM
of each primer, and 1 U of Phusion DNA Polymerase
(Finnzymes). The PCR conditions were as follows: initial
denaturation at 98°C for 30 seconds, followed by 40
cycles of amplification at 98°C for 7 seconds, 59°C for
20 seconds and 72°C for 48 seconds followed by a final
extension step at 72 °C for 5 minutes. The amplified
products were cloned into Zero Blunt® vector according
to the manufacturer’s instructions (cat. No. K2700-20;
Invitrogen, USA). At least 20 colonies from each of
transformation reactions were screened using the rPLU6
and rPLU5 primers. Amplification was done in a 20 μl
reaction mixture containing 1× reaction buffer (5×
Green Go Taq Flexi Buffer, Promega Madison USA),
2m MM g C l 2 (Promega), 200 mM of each dNTP (Pro-
mega), 300 nM of each primer and 0.5 U Go Taq DNA
polymerase (Promega,). PCR conditions were as follows:
initial denaturation of 94°C for 10 minutes, followed by
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ing at 55°C at 1 minute, extension at 72°C for 1 minute
30 seconds, followed by a final extension step at 72°C at
10 minutes. Plasmids from clones having the correct
insert were extracted using QIAprep® Spin Miniprep kit
(QIAgen, cat. no. 27106, Germany) following the manu-
facturer’s instructions. Purified plasmid containing the
insert was sequenced in both directions using the ABI
PRISM® BigDye
™ terminator v3.0 Ready Reaction Cycle
Sequencing Kit (Applied Biosystems, USA) in an 3700
DNA Analyzer (Applied Biosystems, USA).
Phylogenetic analysis
DNA sequences (forward and reverse) were edited and
the consensus sequence was created using the BioEdit.
Consensus sequences were multiple-aligned with pre-
viously published sequences from the GenBank database
using MEGA4 software http://www.megasoftware.net.
Phylogenetic analysis was performed with the MEGA4
software. Two types of phylogenetic analysis were used
on the aligned sequences to assess relationships among
isolates; a distance-based Neighbor-Joining (NJ) analysis
was performed calculated with the Kimura 2-parameter
[17], and Maximum Parsimony (MP) analysis was per-
formed using the Close-Neighbour-Interchange algo-
rithm [18]. The reliability of the trees was assessed by
the bootstrap method with 1,000 replications [19]. Simi-
larity searches were carried out using the Basic Local
Alignment Search Tool (BLAST) [20].
Results
A total of 511 blood samples from febrile patients were
screened by using 18 s rRNA-based nested PCR. Of the
511 samples, 86 (16.8%) were positive for malaria.
A majority of the malarial infections were due to P. falci-
parum (80.3%). Plasmodium vivax infections were seen
in only 5.8% of the samples. Double infections with P. fal-
ciparum + P. vivax (11.6%) and P. falciparum + P. malar-
iae (2.3%) were also detected (Table 1). The PCR product
of 13 P. falciparum isolates and four of P. vivax were
selected from different geographical areas including the
coastal area, the hinterland and the highland malaria
endemic areas, and subjected to cloning and sequencing.
The 17 sequences representing P. falciparum and P.
vivax from this study (Table 2) and 13 sequences repre-
senting human, bird and primate malaria from the Gen-
Bank database, were multiple aligned and analysed using
the Neighbor-Joining (NJ) and Maximum Parsimony
(MP) methods.
The NJ method (Figure 1) shows a main cluster for
P. falciparum and P. reichenowi, the chimpanzee malaria
(100 bootstrap). Within this main cluster, the Yemen
P. facliparum isolates were placed into three sub-clus-
ters. The first sub-cluster includes 8 isolates which
grouped with P. falciparum 3 D 7( G e n B a n kA c c e s s i o n
number AE014186) (100 bootstrap). The second sub-
cluster comprises 4 Yemen isolates and P. falciparum
Papua New Guinea (GenBank Accession number
AF145334) (100 bootstrap). The Yemen P. falciparum
isolate R73 diverged from other isolates and clustered
with P. falciparum (GenBank Accession number
AL844506) (99 bootstrap). The four Yemen isolates of
P. vivax were grouped in one cluster with P. vivax Sal-
vador1 (GenBank Accession number U03079) (100
bootstrap). The monkey malaria parasites (P. cynomolgi
and P. knowlesi) were grouped with human P. vivax in
one cluster (100 bootstrap). Bird malaria parasites (P.
gallinaceum and P. lophurae) formed a separate cluster
(100 bootstrap). The maximum parsimony tree (Addi-
tional file 1) is concordant in topology with the NJ tree.
The thirteen 18 s rRNA sequences of Yemen isolates
of P. falciparum were multiple aligned against the 1135-
nucleotide sequence of 18 s rRNA of P. falciparum 3D7
(GenBank Accession number AE014186) to investigate
the genetic diversity of P. falciparum in Yemen
Table 1 Distribution of malaria species in the study
population
Variable Percentage
Species
P. falciparum 69 (80.3%)
P. vivax 5 (5.8%)
P. falciparum &P. vivax 10 (11.6%)
P. falciparum &P. malariae 2 (2.3%)
Table 2 Yemen isolates of P. falciparum and P. vivax used
in the phylogenetic analysis
SN ID Species Geographical
areas
GenBank Accession
No.
3 D122 P. falciparum Dhamar HQ283210
6 D124 P. falciparum Dhamar HQ283211
11 H12 P. falciparum Hodiedah HQ283212
2 H61 P. falciparum Hodiedah HQ283213
13 H87 P. falciparum Hodiedah HQ283214
10 R73 P. falciparum Raymah HQ283215
9 R117 P. falciparum Raymah HQ283216
5 T71 P. falciparum Taiz HQ283217
7 T91 P. falciparum Taiz HQ283218
4 T113 P. falciparum Taiz HQ283219
1 T116 P. falciparum Taiz HQ283220
8 T122 P. falciparum Taiz HQ283221
12 T124 P. falciparum Taiz HQ283222
17 D24 P. vivax Dhamar HQ283223
14 H15 P. vivax Hodiedah HQ283224
16 H108 P. vivax Hodiedah HQ283225
15 H120 P. vivax Hodiedah HQ283226
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substitutions, 1 insertion and 5 deletions). Isolates H61
and D122 showed 6 SNP (1 substitution and 5 dele-
tions) and 8 SNP (1 substitution, 4 insertions and 3
deletions), respectively. Isolates T122 and T113 showed
7 SNP (1 substitution, 1 insertion and 5 deletions). Iso-
lates D124, T116 and T71 had 10 SNP (10 deletions).
Isolates R117, H12, T91 and H87, which were clustered
together in the phylogenetic analysis, showed poly-
morphism in 5% of the 1135-nucleatide sequence. The
h i g h e s tp o l y m o r p h i s m( 1 4 . 8 % )w a sn o t e di nt h ei s o l a t e
R73 which diverged in a separated cluster in the phylo-
genetic trees. The four sequences of the Yemen isolates
of P. vivax were also aligned against 1058-nucleotide
sequence of P. vivax Salvador1 (GenBank Accession
number U03079). The isolate H108 had 7 SNP (6 sub-
stitutions and 1 insertion). The isolate H15 had 7 SNP
(5 substitutions and 2 insertions). The isolates D24 and
H124 showed 5 SNP (5 substitutions).
To determine whether the genetic diversity is due to
the heterogeneous types of Plasmodium 18 s rRNA or
not, phylogenetic trees were re-constructed based on
our sequences and sequences representing different
types of Plasmodium 18 s rRNA (A, O or S type) from
the GenBank database. Both the NJ tree (Figure 2) and
MP tree (Additional file 3) were consistent, placing all
the Yemen isolates of P. falciparum except isolate R73
into one cluster and clade with P. falciparum type-S
(GenBank Accession number M19173) (100 bootstrap).
The isolate R73 was much closer to P. falciparum 18 s
rRNA type-A (GenBank Accession number M19173)
(100 bootstrap). All P. vivax isolates were grouped with
P. vivax type-A in one cluster (GenBank Accession
number U07367) (100 bootstrap).
Discussion
This is the first study to apply molecular techniques to
study the epidemiology andp h y l o g e n yo fm a l a r i ai n
Yemen. Malaria infection rate, using 18 s rRNA-based
nested PCR, was 16.8% which is comparable with previous
studies carried out in Yemen based on Giemsa microscopy
[15,21-25]. PCR results showed that approximately 12% of
the positive malaria cases were mixed infection of P. falci-
parum and P. vivax or P. malariae which is a higher rate
than has been hitherto reported. The high proportion of
Figure 1 Neighbor-Joining (NJ) tree, constructed based on the
nucleotide sequences of 18 s rRNA, displaying the
relationships of 17 sequences representing 13 P. Falciparum
isolates and 4 sequences representing 4 P. Vivax isolates.
Bootstrap support of more than 80% is indicated. Bold-type
represents reference sequences for Plasmodium species from
GenBank.
Figure 2 Neighbor-Joining (NJ) tree, constructed based on the
nucleotide sequences representing the different types of 18 s
rRNA (A, O or S type) from GeneBank and 13 sequences
representing 13 P. falciparum isolates and 4 sequences
representing 4 P. Vivax isolates from this study. Bootstrap
support of more than 90% is indicated. Bold-type represents
reference sequences for Plasmodium species from GenBank.
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explained by the high sensitivity of PCR [26] and the low
level parasitaemia of the dominated species which is under
the diagnostic threshold of Giemsa microscopy. Accurate
identification of mixed infection with malaria species is
very important for proper clinical case management.
Malaria treatment policy differs depending on the infect-
ing species. Thus, in the case of mixed infection, if only
one species is treated, the other may establish a new epi-
sode of malaria.
Plasmodium falciparum is the dominant malaria spe-
cies in Yemen followed by P. vivax, whereas P. malariae
has rarely been reported in Yemen. The current study
highlighted the possibility that P. malariae is distributed
more than expected and it is often overlooked due to
low levels of parasitaemia and the shortcoming of
microscopy, the only techniq u eu s e df o rm a l a r i ad e t e c -
tion and identification in the country. Furthermore, P.
malariae may be obscured by the dominant species.
The underestimation of P. malariae distribution has
been reported in other countries [27-30]
Phylogenetic analysis using the NJ method grouped
Yemen isolates of P. falciparum into one main cluster.
Within the main cluster, the Yemen isolates were placed
in three sub-clusters (Figure 1). These clusters were sup-
ported by cladograms using the MP method. One sub-
cluster contained 8 isolates and P. falciparum 3D7 (Gen-
Bank Accession number AE014186) [31]. The second sub-
cluster included four isolates and P. falciparum (GenBank
Accession number AF145334) which was isolated from
Papua New Guinea [32]. The isolate R73 formed a sepa-
rate cluster with P. falciparum (GenBank Accession num-
ber AL844506). Phylogenetic analysis based on our
sequences and sequences from the GenBank representing
the secondary structure of 18 s rRNA showed that isolate
R73 that diverged in a separate cluster may be A-type
ribosomal rRNA, while the other two sub-clusters are S-
type rRNA. Thus, genetic diversity within the Yemen iso-
lates that grouped in one cluster with the S-type rRNA
may be not due to the heterogeneity of 18 s rRNA genes.
Genetic diversity may provide a mechanism for drug resis-
tance which may affect any intervention strategy based on
treatment. Furthermore, PCR-based specific diagnosis of
Plasmodium species may fail due to sequence variations in
the priming regions, thus leading to false negative results.
The low sensitivity of PCR-based diagnosis due to genetic
mutations has been previously reported [30].
Conclusions
In conclusion, malaria is a major public health problem
in Yemen. Although P. falciparum is predominant, P.
vivax, P. malariae and mixed infections are more preva-
lent than has been revealed by microscopy. This over-
looked distribution should be considered by malaria
control strategy makers. Sequences from P. falciparum
isolates showed high genetic polymorphisms that may
not be related to the variants of ribosomal RNA
expressed in the different stages of malaria parasites
which warrant further studies.
Additional material
Additional file 1: Maximum Parsimony (MP) tree . The tree was
constructed based on the nucleotide sequences of 18 s rRNA, displaying
the relationship of 17 sequences representing 13 P. falciparum isolates
and 4 sequences representing 4 P. vivax isolates. Bootstrap support of
more than 60% is indicated. Bold-type represents reference sequences
for Plasmodium species from GenBank.
Additional file 2: Multiple alignment of partial 18 s rRNA sequences.
Multiple alignment of partial 18 s rRNA sequences of Yemen Plasmodium
falciparum isolates against P. falciparum 3D7 (GenBank accession
numbers AE014186). Dots represent sequence identities. Dashes denote
no nucleotides.
Additional file 3: Maximum parsimony (MP) tree. The tree was
constructed based on nucleotide sequences representing the different
types of 18 s rRNA (A, O or S type) from GeneBank and 13 sequences
representing 13 P. falciparum isolates and 4 sequences representing 4 P.
vivax isolates from this study. Bootstrap support of more than 90% is
indicated. Bold-type represents reference sequences for Plasmodium
species from GenBank.
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